New Delhi: The Central government has given license to five companies to ramp up the production of Liposomal Amphotericin B injections, which is used to treat black fungus or mucormycosis, the sources said.
The sources said Gilead Sciences in the US is working on expediting the supply of AmBisome to India through Mylan.
Read:| Amphotericin-B Emulsion injections manufacturing beings in Maharashtra, each vial to cost Rs 1200
Sources further stated that more than 1,21,000 vials of AmBisome have reached India so far and another 85,000 vials of the drug are on the way.
The company will supply 1 million doses of AmBisome to India through Mylan, the sources said.
The Union Minister for Chemicals and Fertilizers Sadananda Gowda yesterday informed that additional 29,250 vials of Amphotericin B, used in the treatment of Mucormycosis, were allocated to states and Union Territories, based on their number of patients under treatment.
Read:| India reports 11,717 mucormycosis cases, 29K more Amphotericin vials allocated
Earlier, additional 19,420 vials of Amphotericin-B were allocated on May 24 and 23,680 vials of the drug were supplied across the country on May 21, the Ministry of Chemicals and Fertilizers informed.
ANI
Read:| 15 Lakh vials of Amphotericin-B will be available by next month: Mansukh Mandaviya
